Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction-Reference-Cited by-同舟云学术

Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction

Published:2022-06 Issue: Volume:167 Page:40-51
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Wang Yong-Li,Bai Lan,Shi Xue-Rui,Zhu Hong,Du Lin-Juan,Liu Yuan,Ma Xiao-Xin,Lin Wen-Zhen,Liu Ting,Sun Jian-Yong,Liu Yan,Guo Xu-Guang,Zhou Lu-Jun,Chen Bo-Yan,Shao Shuai,Meng Xiao-Qian,Li Yu-Lin,Li Ruo-Gu,Duan Sheng-Zhong

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference52 articles.

1. Perioperative cardiovascular risk assessment and management for noncardiac surgery: a review;Smilowitz;JAMA,2020

2. Pathological ventricular remodeling: mechanisms: part 1 of 2;Burchfield;Circulation.,2013

3. Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials;von Haehling;Eur. J. Heart Fail.,2020

4. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials;Kapelios;Heart Fail. Rev.,2019

5. New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure;Capelli;J. Nephrol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-Cell Mineralocorticoid Receptor Deficiency Attenuates Pathologic Ventricular Remodelling After Myocardial Infarction;Canadian Journal of Cardiology;2023-05